These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 29936333)

  • 1. Depletion of Ubiquilin induces an augmentation in soluble ubiquitinated Drosophila TDP-43 to drive neurotoxicity in the fly.
    Jantrapirom S; Lo Piccolo L; Yoshida H; Yamaguchi M
    Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):3038-3049. PubMed ID: 29936333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new Drosophila model of Ubiquilin knockdown shows the effect of impaired proteostasis on locomotive and learning abilities.
    Jantrapirom S; Lo Piccolo L; Yoshida H; Yamaguchi M
    Exp Cell Res; 2018 Jan; 362(2):461-471. PubMed ID: 29247619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of amyotrophic lateral sclerosis (ALS)-associated TDP-43 aggregation by the proteasome-targeting factor, ubiquilin 1.
    Kim SH; Shi Y; Hanson KA; Williams LM; Sakasai R; Bowler MJ; Tibbetts RS
    J Biol Chem; 2009 Mar; 284(12):8083-92. PubMed ID: 19112176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation-dependent aggregation and toxicity in a Drosophila model for UBQLN2-associated ALS.
    Kim SH; Stiles SG; Feichtmeier JM; Ramesh N; Zhan L; Scalf MA; Smith LM; Pandey UB; Tibbetts RS
    Hum Mol Genet; 2018 Jan; 27(2):322-337. PubMed ID: 29161404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TDP-43 mediates degeneration in a novel Drosophila model of disease caused by mutations in VCP/p97.
    Ritson GP; Custer SK; Freibaum BD; Guinto JB; Geffel D; Moore J; Tang W; Winton MJ; Neumann M; Trojanowski JQ; Lee VM; Forman MS; Taylor JP
    J Neurosci; 2010 Jun; 30(22):7729-39. PubMed ID: 20519548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel Drosophila model of TDP-43 proteinopathies: N-terminal sequences combined with the Q/N domain induce protein functional loss and locomotion defects.
    Langellotti S; Romano V; Romano G; Klima R; Feiguin F; Cragnaz L; Romano M; Baralle FE
    Dis Model Mech; 2016 Jun; 9(6):659-69. PubMed ID: 27101846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PABPN1 suppresses TDP-43 toxicity in ALS disease models.
    Chou CC; Alexeeva OM; Yamada S; Pribadi A; Zhang Y; Mo B; Williams KR; Zarnescu DC; Rossoll W
    Hum Mol Genet; 2015 Sep; 24(18):5154-73. PubMed ID: 26130692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles for the VCP co-factors Npl4 and Ufd1 in neuronal function in Drosophila melanogaster.
    Byrne DJ; Harmon MJ; Simpson JC; Blackstone C; O'Sullivan NC
    J Genet Genomics; 2017 Oct; 44(10):493-501. PubMed ID: 29037990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of ubiquilin 2 and TDP-43 aggregates throughout the CNS in UBQLN2 p.T487I-linked amyotrophic lateral sclerosis and frontotemporal dementia.
    Nementzik LR; Thumbadoo KM; Murray HC; Gordon D; Yang S; Blair IP; Turner C; Faull RLM; Curtis MA; McLean C; Nicholson GA; Swanson MEV; Scotter EL
    Brain Pathol; 2024 May; 34(3):e13230. PubMed ID: 38115557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UBQLN2/ubiquilin 2 mutation and pathology in familial amyotrophic lateral sclerosis.
    Williams KL; Warraich ST; Yang S; Solski JA; Fernando R; Rouleau GA; Nicholson GA; Blair IP
    Neurobiol Aging; 2012 Oct; 33(10):2527.e3-10. PubMed ID: 22717235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal Expression of UBQLN2
    Picher-Martel V; Renaud L; Bareil C; Julien JP
    Mol Neurobiol; 2019 Jul; 56(7):4680-4696. PubMed ID: 30377984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of Motor Defects Caused by Loss of
    Lembke KM; Scudder C; Morton DB
    J Neurosci; 2017 Sep; 37(39):9486-9497. PubMed ID: 28847811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral expression of ALS-linked ubiquilin-2 mutants causes inclusion pathology and behavioral deficits in mice.
    Ceballos-Diaz C; Rosario AM; Park HJ; Chakrabarty P; Sacino A; Cruz PE; Siemienski Z; Lara N; Moran C; Ravelo N; Golde TE; McFarland NR
    Mol Neurodegener; 2015 Jul; 10():25. PubMed ID: 26152284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of
    Kushimura Y; Tokuda T; Azuma Y; Yamamoto I; Mizuta I; Mizuno T; Nakagawa M; Ueyama M; Nagai Y; Yoshida H; Yamaguchi M
    Am J Neurodegener Dis; 2018; 7(1):11-31. PubMed ID: 29531866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An age-related reduction of brain TBPH/TDP-43 levels precedes the onset of locomotion defects in a Drosophila ALS model.
    Cragnaz L; Klima R; De Conti L; Romano G; Feiguin F; Buratti E; Baralle M; Baralle FE
    Neuroscience; 2015 Dec; 311():415-21. PubMed ID: 26518462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drosophila TDP-43 dysfunction in glia and muscle cells cause cytological and behavioural phenotypes that characterize ALS and FTLD.
    Diaper DC; Adachi Y; Lazarou L; Greenstein M; Simoes FA; Di Domenico A; Solomon DA; Lowe S; Alsubaie R; Cheng D; Buckley S; Humphrey DM; Shaw CE; Hirth F
    Hum Mol Genet; 2013 Oct; 22(19):3883-93. PubMed ID: 23727833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modelling TDP-43 proteinopathy in Drosophila uncovers shared and neuron-specific targets across ALS and FTD relevant circuits.
    Godfrey RK; Alsop E; Bjork RT; Chauhan BS; Ruvalcaba HC; Antone J; Gittings LM; Michael AF; Williams C; Hala'ufia G; Blythe AD; Hall M; Sattler R; Van Keuren-Jensen K; Zarnescu DC
    Acta Neuropathol Commun; 2023 Oct; 11(1):168. PubMed ID: 37864255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTK2/FAK regulates UPS impairment via SQSTM1/p62 phosphorylation in TARDBP/TDP-43 proteinopathies.
    Lee S; Jeon YM; Cha SJ; Kim S; Kwon Y; Jo M; Jang YN; Lee S; Kim J; Kim SR; Lee KJ; Lee SB; Kim K; Kim HJ
    Autophagy; 2020 Aug; 16(8):1396-1412. PubMed ID: 31690171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TDP-43 proteinopathy and mitochondrial abnormalities in neurodegeneration.
    Gao J; Wang L; Yan T; Perry G; Wang X
    Mol Cell Neurosci; 2019 Oct; 100():103396. PubMed ID: 31445085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA binding mediates neurotoxicity in the transgenic Drosophila model of TDP-43 proteinopathy.
    Ihara R; Matsukawa K; Nagata Y; Kunugi H; Tsuji S; Chihara T; Kuranaga E; Miura M; Wakabayashi T; Hashimoto T; Iwatsubo T
    Hum Mol Genet; 2013 Nov; 22(22):4474-84. PubMed ID: 23804749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.